Navigation Links
Miltenyi Biotec GmbH Acquires Medic Tools AG
Date:6/10/2008

BERGISCH GLADBACH, Germany, June 10 /PRNewswire/ -- Miltenyi Biotec has acquired Medic Tools AG from Zug, Switzerland. With this acquisition, Miltenyi Biotec strengthens the portfolio in the area of sample preparation. "The innovative and high-quality devices and techniques fit perfectly into the product range of instruments, reagents, and services offered by Miltenyi Biotec", Miltenyi Biotec CEO Dr. Boris Stoffel and Franz G. Bucher, Vice President and CEO of Medic Tools AG, stated in a conjoint announcement.

As a first result of the previous cooperation, the gentleMACS(TM) Dissociator was introduced into the market several months ago. The instrument facilitates the generation of single-cell suspensions from tissues and thus, helps generate the ideal starting material for the separation and isolation of specific cell types using MACS(R) Technology. This procedure to separate cells magnetically was developed by Miltenyi Biotec and is a research laboratory standard worldwide.

The additional expertise of Medic Tools enables Miltenyi Biotec to further engage in development projects in the area of sample preparation. "We offer our biomedical research customers a complete solution", adds Dr. Stoffel, "from sample preparation to cell separation, cell analysis, cytological and molecular analysis."

The involved parties agreed that financial details of the transaction should not be disclosed.

About Miltenyi Biotec

The company is one of the largest and most successful biotechnology companies in Germany. More than 1,100 employees develop, produce and sell products for biomedical research and clinical applications. The renowned MACS Technology for magnetic separation of cells has become a standard technology in research laboratories worldwide.

Contact:

Prof. Dr. Uwe Heinlein, Corporate Communications, Miltenyi Biotec GmbH

Friedrich-Ebert-Str. 68, 51429 Bergisch Gladbach, Germany

Phone +49-2204-8306-6590, E-mail uweh@miltenyibiotec.de

http://www.miltenyibiotec.com


'/>"/>
SOURCE Miltenyi Biotec GmbH
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
2. Brazils biotech firms: From imitators to innovators in health-related products
3. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
4. Gen-Probe to Webcast Presentation at Seventh Annual Needham Biotechnology and Medical Technology Conference
5. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
6. InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences
7. Hologic to Present at the Needham Seventh Annual Biotechnology and Medical Technology Conference
8. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
9. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
10. Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
11. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Arrowhead Publishers is pleased to ... coming to San Diego, CA on September 27-28, 2017. Leaders from the pharmaceutical, ... advances in the treatment of various types of pain. There are also extended ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... comprehensive rebrand and a name change to Fluence Analytics. , Fluence ... monitoring of polymer and biopharmaceutical manufacturing processes and R&D applications. The company’s ...
(Date:4/27/2017)... NASHVILLE, Tenn. , April 27, 2017  Pendant ... company developing innovative surface modification and drug delivery technologies, ... & Johnson Innovation, JLABS @ Toronto ... Chief Executive Officer of Pendant Biosciences, noted, "We are ... Toronto community, and are honored to ...
(Date:4/26/2017)... ... April 26, 2017 , ... WonderWorks, Myrtle Beach’s science ... the future of deep space exploration and inspire space enthusiasts. The exhibit features ... includes a guest appearance by former Shuttle Astronaut Don Thomas. , The intergalactic ...
Breaking Biology Technology:
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... GARDENS, Fla. , April 11, 2017 /PRNewswire/ ... management and secure authentication solutions, today announced that ... by Intelligence Advanced Research Projects Activity (IARPA) to ... IARPA,s Thor program. "Innovation has been ... and IARPA,s Thor program will allow us to ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
Breaking Biology News(10 mins):